Francesca Butera
Institute of Cancer Research(GB)
Publications by Year
Research Areas
Virus-based gene therapy research, interferon and immune responses, CRISPR and Genetic Engineering, PARP inhibition in cancer therapy, Bacterial Genetics and Biotechnology
Most-Cited Works
- → DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression(2017)432 cited
- → ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma(2019)73 cited
- → Environmentally dependent and independent control of 3D cell shape(2024)12 cited
- → Epithelial-Mesenchymal Plasticity is regulated by inflammatory signalling networks coupled to cell morphology(2019)9 cited
- → Actin networks modulate heterogeneous NF-κB dynamics in response to TNFα(2024)6 cited
- → The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models(2025)4 cited
- → Actin networks modulate heterogenous NF-κB dynamics in response to TNFα(2022)1 cited
- → Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion(2025)1 cited
- → Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion(2025)1 cited
- → Author response: Actin networks modulate heterogeneous NF-κB dynamics in response to TNFα(2024)